Huriez syndrome: Case report with a detailed analysis of skin dendritic cells

British Journal of Dermatology

Volumn 143, Issue 5, 2000, Pages 1091-1096

  Guerriero, C ^a   Albanesi, C ^a   Girolomoni, G ^a   De Simone, C ^a   Capizzi, R ^a   Amerio, P ^a   Tulli, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Huriez syndrome; Immunohistochemistry; Langerhans cells; Squamous cell carcinoma

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD1B ANTIGEN; CELL ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LAG ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PROTEIN S 100; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DENDRITIC CELL; GENODERMATOSIS; HAND PALM; HISTOPATHOLOGY; HUMAN; HURIEZ SYNDROME; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FATAL OUTCOME; HUMANS; KERATODERMA, PALMOPLANTAR; LANGERHANS CELLS; MALE; MIDDLE AGED; SKIN NEOPLASMS; SYNDROME;

EID: 0033739267     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03793.x     Document Type: Article

References (34)

1. Epitheliomas spinocellulaires sur atrophie cutanee congenitale dans deux families a morbidite cancereuse elevee
2. Scleroatrophie des extremites avec degenerescences spinocellulaires multiples
3. Une genodysplasie non encore individualisee: La genodermatose scleroatrophiante et keratodermique des extremites frequemment degenerative
4. Genodermatose scleroatrophiante et keratodermique des extremites
5. La genodermatose scleroatrophiante et keratodermique des extremites
6. Genodermatose scleroatrophiante et keratodermique des extremites
7. La genodermatose sclero-atophiante et keratodermique des extremites (au sujet de trois nouveaux cas familiaux)
8. Genodermatosis escleroatrophiante y queratodermica de las extremidades frecuentemente degenerativa
9. Palmoplantar keratoderma with sclerodactyly (Huriez syndrome)
10. The scleroatrophic syndrome of Huriez
11. The scleroatrophic syndrome of Huriez: A cancer-prone genodermatosis
12. The scleroatrophic syndrome of Huriez
13. Disorders of connective tissue
14. Distinctive nail changes in scleroatrophy of Huriez
15. Disordini ereditari della cheratinizzazione
16. Keratoderma with scleratrophy of the extremities or sclerotylosis (Huriez syndrome): A reappraisal
17. Effects of immunomodulatory cytokines on the presentation of tumor associated antigens by epidermal Langerhans cells
18. Dendritic cells
19. Immune dendritic cells in human dermis
20. Interleukin-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes. Synergistic or antagonist effects with interferon-γ and tumor necrosis factor-α
21. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3 alpha and MIP-3 beta
22. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells
23. Granulocyte/macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin
24. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
25. Immunological and histochemical analysis of regional variations of epidermal Langerhans cells in normal human skin
26. Distribution of ATPase-positive Langerhans cells in normal adult human skin
27. The distribution and quantification of the Langerhans cell in normal human epidermis
28. Flow cytometrically-sorted residual HLA-DR+ T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity
29. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: Relationship to dose, CD1a- DR+ epidermal macrophage induction, and Langerhans cell depletion
30. A role for TGFβ1 in Langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFβ1 null mice
31. TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells
32. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-β1-dependent manner
33. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells
34. Macrophage inflammatory protein 3α is involved in the constitutive traffic of epidermal Langerhans cells